Igenomix Canada

Igenomix Canada 🤰🏻 We work to enable people to fulfill the dream of having a healthy baby. IGENOMIX USA is a company that provides advanced services in reproductive genetics.

Our broad experience and qualifications make us one of the global leaders in this field, and we guarantee we will offer you effective solutions to various different infertility problems.

Visit us at CFAS West Coast Regional Meeting in Vancouver today!
05/02/2025

Visit us at CFAS West Coast Regional Meeting in Vancouver today!

🧬 Do you know the differences between Trisomy and Triploidy? While both conditions involve an abnormal number of chromos...
01/23/2025

🧬 Do you know the differences between Trisomy and Triploidy? While both conditions involve an abnormal number of chromosomes, the implications are different.

Trisomy occurs when there is an extra copy of a chromosome, resulting in three copies instead of the usual two; a person with trisomy will have 47 chromosomes instead of 46. Trisomy pregnancies often result in a live birth of an individual with conditions such as Down Syndrome (Trisomy 21), Edward’s Syndrome (Trisomy 18), and Patau Syndrome (Trisomy 13). However, many trisomic pregnancies result in spontaneous miscarriage.

Triploidy involves the presence of an additional set of chromosomes. Instead of having 46 chromosomes (23 pairs), a triploid cell has 69 chromosomes (three sets of 23). This condition is typically incompatible with life, often resulting in miscarriage, molar pregnancy, or severe developmental abnormalities if carried to term.

Current technologies utilizing next generation sequencing (NGS) cannot detect the ploidy status of embryos. Consequently, apparently euploid embryos may have a triploid or haploid constitution.

🥼With the screening of both trisomy and triploidy, our Smart PGT-A Plus empowers the physician with more informed decision-making for embryo transfer.

EMMA 🧬 (Endometrial Microbiome Metagenomic Analysis) offers the most comprehensive and precise panel, encompassing the h...
01/07/2025

EMMA 🧬 (Endometrial Microbiome Metagenomic Analysis) offers the most comprehensive and precise panel, encompassing the highest amount of frequently detected and clinically relevant bacteria to evaluate the endometrium at the microbiological level. 🦠

After more than 5 years of development analyzing over 70,000 clinical samples, the upgraded EMMA panel now identifies bacteria at the species level, enabling more precise and targeted treatments.

Click the to learn more.

Missed this year? We’re sharing all the booth presentations given by leading scientific and industry experts including...
12/12/2024

Missed this year? We’re sharing all the booth presentations given by leading scientific and industry experts including this one from CSO Denny Sakkas. 👏

📌Dr. Sakkas explains that as the blastocyst develops, it actively releases DNA into the culture media. His most recent publication demonstrates that extending embryo culture to day 6 for niPGT-A screening does not compromise embryo viability or affect pregnancy outcomes, making it a safe alternative for patients who wish to avoid embryo biopsy while still pursuing chromosomal testing.

The Vitrolife Group was pleased to sponsor the CFAS/ASRM Business in Medicine Summit in Banff, Alberta. Blair and Alissa...
07/21/2024

The Vitrolife Group was pleased to sponsor the CFAS/ASRM Business in Medicine Summit in Banff, Alberta. Blair and Alissa had a great time catching up with friends and colleagues, old and new!

Wha

ERA works when applied in the indicated population (RIF) and when adhering to proper protocol compliance. When ERA is us...
06/10/2024

ERA works when applied in the indicated population (RIF) and when adhering to proper protocol compliance.
When ERA is used correctly, you can maximize the chances of embryo implantation and further optimize patient outcomes.

💻 Today we want to share a useful clinical tool that can be used both in office and with patients. The ERA Checklist helps organize ERA mock and personalized embryo transfer (pET) cycles, ensuring proper protocol compliance and reproducibility, with the aim to further improve clinical outcomes. 🤰

👉 Link here to visit the complete ERA hub: ERA works worldwide - https://ow.ly/QGz150SbtUA
👉 Link here to download the ERA Checklist: https://ow.ly/1KVV50SbtUy

📢📢 Exciting news! It is a pleasure to share with you a new digital hub where you can access helpful information and clin...
06/04/2024

📢📢 Exciting news! It is a pleasure to share with you a new digital hub where you can access helpful information and clinical tools pertaining to our ERA test.

As you well know, ERA works when applied in the indicated population (RIF) and when adhering to proper protocol compliance. When ERA is used correctly, you can maximize the chances of embryo implantation and further optimize patient outcomes.

💻 This new digital tool features:

✔️Physician-user testimonials from around the world
✔️Tips from our scientific community
✔️Clinic ERA tools
✔️Webinars that focus on protocol compliance
And much more!

We will continue to update the ERA digital hub with new content to support you, so together we can help your patients achieve their goal of a healthy pregnancy. 🤰

Visit our new ERA hub: https://www.igenomix.eu/era-works-worldwide/

ERA works when applied in the indicated population (RIF) and when adhering to proper protocol compliance.When ERA is use...
05/29/2024

ERA works when applied in the indicated population (RIF) and when adhering to proper protocol compliance.

When ERA is used correctly, you can maximize the chances of embryo implantation and further optimize patient outcomes.

💻 Today we want to share a useful clinical tool that can be used both in office and with patients. The ERA Checklist helps organize ERA mock and personalized embryo transfer (pET) cycles, ensuring proper protocol compliance and reproducibility, with the aim to further improve clinical outcomes. 🤰

Link here to visit the complete ERA hub: ERA works worldwide - https://www.igenomix.eu/era-works-worldwide/

Link here to download the ERA Checklist:https://www.igenomix.eu/wp-content/uploads/sites/25/2024/05/ERA-Checklist.pdf

🔬 Exciting News Alert! Join us for our upcoming webinar hosted by Igenomix! 🔬📅 Date: May 16th🕒 Time: 11am PST / 2pm EST🔗...
05/13/2024

🔬 Exciting News Alert! Join us for our upcoming webinar hosted by Igenomix! 🔬

📅 Date: May 16th
🕒 Time: 11am PST / 2pm EST
🔗 Registration Link: https://register.gotowebinar.com/register/726602802566427740?utm_source=Marketing_Cloud&utm_medium=email&utm_campaign=USA+-+CGT+Webinar+-+Closing+the+Gap+on+Carrier+Screening+by+Igenomix&utm_term=CLICK+HERE&utm_id=1094878&sfmc_id=438174598

Empowering informed decisions in genetic health is at the core of what we do at Igenomix. That's why we're thrilled to extend an exclusive invitation to you for our upcoming webinar, "Closing the Gaps in Carrier Screening."

Carrier Genetic Testing (CGT) is revolutionizing genetic screening, offering unparalleled insights into potential risks that could affect future generations. Join us as we explore how CGT, powered by whole exome sequencing (WES), is transforming reproductive health decisions.

Explore the impact of CGT with our expert panel.

Don't miss out!

🔬 Exciting News Alert! Join us for our upcoming webinar hosted by Igenomix! 🔬📅 Date: May 16th🕒 Time: 11am PST / 2pm EST🔗...
05/03/2024

🔬 Exciting News Alert! Join us for our upcoming webinar hosted by Igenomix! 🔬

📅 Date: May 16th
🕒 Time: 11am PST / 2pm EST
🔗 Registration: https://attendee.gotowebinar.com/register/726602802566427740

Empowering informed decisions in genetic health is at the core of what we do at Igenomix. That's why we're thrilled to extend an exclusive invitation to you for our upcoming webinar, "Closing the Gaps in Carrier Screening."

Carrier Genetic Testing (CGT) is revolutionizing genetic screening, offering unparalleled insights into potential risks that could affect future generations. Join us as we explore how CGT, powered by whole exome sequencing (WES), is transforming reproductive health decisions.

Explore the impact of CGT with our expert panel.

Don't miss out!

Vitrolife Group acquires eFertility, an innovative system and software company transforming IVF clinic management with c...
05/03/2024

Vitrolife Group acquires eFertility, an innovative system and software company transforming IVF clinic management with cutting edge solutions.

We are delighted to announce that today, the Vitrolife Group successfully completed the acquisition of eFertility. This acquisition is a key element of the Vitrolife Group’s strategy to bring increased standardisation and digitalisation to IVF clinics around the world.

“The acquisition of eFertility represents a significant step in the Vitrolife Group’s strategy to transform and digitalise the IVF patient journey. By incorporating eFertility’s technologies into our platform, we are making critical advancements towards the development of a seamlessly integrated and more efficient clinic workflow." said Bronwyn Brophy, CEO of Vitrolife Group.

Read the full press release here: https://www.vitrolifegroup.com/en/investor-relations/press-releases?page=/en/press/vitrolife-ab-publ-acquires-efertility

Vitrolife and Igenomix, both part of , are excited to meet you at the 21st PGDIS Conference in Kuala Lumpur, Malaysia, ...
05/03/2024

Vitrolife and Igenomix, both part of , are excited to meet you at the 21st PGDIS Conference in Kuala Lumpur, Malaysia, from May 6th to 8th.

If you're in attendance, we welcome you to stop by Booth B1 to explore our high-quality solutions tailored to enhance your lab or clinic capabilities.

See you at Booth B1!

Address

2780 Slough Street
Mississauga, ON
L4T1G3

Opening Hours

Monday 8am - 8pm
Tuesday 8am - 8pm
Wednesday 8am - 8pm
Thursday 8am - 8pm
Friday 8am - 8pm

Website

Alerts

Be the first to know and let us send you an email when Igenomix Canada posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Igenomix Canada:

Shortcuts

Share

Category